Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC

Download this slideset to review the latest clinical data supporting the optimal use of checkpoint inhibitor therapy in patients with stage III NSCLC, including expert guidance on management of immunotherapy-related pulmonary toxicity.
Gerard A. Silvestri, MD, MS
Program Director
Kristin Higgins, MD
Mark A. Socinski, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.36 MB
Released: October 21, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Gain key clinical insights fast with this short slideset from CCO on RET fusion–positive NSCLC

Dara L. Aisner, MD, PhD Joshua Bauml, MD Released: September 17, 2020

Gain key expert insights fast with this short slideset from CCO on biomarkers critical to optimal use of targeted therapy and immunotherapy for NSCLC

Matthew Gubens, MD, MS Sanjay Mukhopadhyay, MD Released: September 11, 2020

Downloadable slideset on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in NSCLC, from Clinical Care Options (CCO)

Matthew Gubens, MD, MS Released: September 11, 2020

Downloadable slideset on best practices when biopsying and testing for NSCLC biomarkers, from Clinical Care Options (CCO)

Sanjay Mukhopadhyay, MD Released: September 11, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?